Cargando…
A Schistosoma japonicum chimeric protein with a novel adjuvant induced a polarized Th1 immune response and protection against liver egg burdens
BACKGROUND: Schitosomiasis japonica is still a significant public health problem in China. A protective vaccine for human or animal use represents an important strategy for long-term control of this disease. Due to the complex life cycle of schistosomes, different vaccine design approaches may be ne...
Autores principales: | Xu, Xindong, Zhang, Dongmei, Sun, Wei, Zhang, Qingfeng, Zhang, Jingjing, Xue, Xiangyang, Shen, Luhui, Pan, Weiqing |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685138/ https://www.ncbi.nlm.nih.gov/pubmed/19419545 http://dx.doi.org/10.1186/1471-2334-9-54 |
Ejemplares similares
-
An “In-Depth” Description of the Small Non-coding RNA Population of Schistosoma japonicum Schistosomulum
por: Wang, Zhangxun, et al.
Publicado: (2010) -
Identification and Characterization of Novel MicroRNAs from Schistosoma japonicum
por: Xue, Xiangyang, et al.
Publicado: (2008) -
Having a pair: the key to immune evasion for the diploid pathogen Schistosoma japonicum
por: Xu, Xindong, et al.
Publicado: (2012) -
Host serum miR-223 is a potential new biomarker for Schistosoma japonicum infection and the response to chemotherapy
por: He, Xing, et al.
Publicado: (2013) -
Identification and characterization of six novel tetraspanins from Schistosoma japonicum
por: Jiang, Yanyan, et al.
Publicado: (2011)